Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 10 Dec 2021 – 20 Aug 2026, limited by HDFC Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC Multi Cap Fund | Nifty 500 |
|---|---|---|
| 10 Dec 2021 | ₹100.00 | ₹100.00 |
| 02 May 2022 | ₹98.73 | ₹97.24 |
| 22 Sep 2022 | ₹109.29 | ₹101.19 |
| 12 Feb 2023 | ₹112.02 | ₹99.08 |
| 04 Jul 2023 | ₹128.24 | ₹109.24 |
| 24 Nov 2023 | ₹145.80 | ₹116.42 |
| 15 Apr 2024 | ₹160.41 | ₹135.13 |
| 05 Sep 2024 | ₹194.91 | ₹156.80 |
| 26 Jan 2025 | ₹173.28 | ₹140.67 |
| 18 Jun 2025 | ₹186.46 | ₹151.27 |
| 07 Nov 2025 | ₹192.26 | ₹155.21 |
| 30 Mar 2026 | ₹158.61 | ₹135.45 |
| 20 Aug 2026 | ₹183.77 | ₹155.15 |
| Metric | HDFC · Direct · IDCW NAV ₹18.42 Very High risk ★★★☆☆ | Category median Multi Cap Fund · 29 funds |
|---|---|---|
| -2.68% | +6.55% | |
| +10.82% | +13.71% | |
| — | +12.07% | |
| — | +9.16% | |
| +13.85% | +14.55% | |
| +11.21% | — | |
| +18.97% | +17.33% | |
| — | +14.39% | |
| — | +9.74% | |
| Risk | ||
| 15.40% | 15.40% | |
| 0.28 | 0.41 | |
| 0.37 | 0.54 | |
| -20.20% | -21.00% | |
| Nifty 500 | — | |
| -1.77% | +1.30% | |
| 1.10 | 1.03 | |
| 100.5% | 104.7% | |
| 111.4% | 99.6% | |
| 0.93% | 0.93% | |
| ₹19,551Cr | ₹4,007Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 44% | 53% | |
| Dhruv Muchhal | — | |
| 10 Dec 2021 | — | |
| 121 | — | |
| 23.9% | — | |
| 0.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.